华芢\生物-B：稳定价格期间结束、无稳定价格行动及超额配股权失效

Core Viewpoint - The stabilization period for the global offering of Huazhong Bio-B (02396) ended on January 16, 2026, with no over-allotment exercised during this period [1] Group 1 - The announcement indicates that the international offering did not involve any over-allocation of shares [1] - The over-allotment option has expired as of January 16, 2026 [1] - The company was informed by the stabilization agent that no stabilization actions were taken during the stabilization period [1]